Drawing for CERVICURA

USPTO serial 79166469

CERVICURA

Reviewed by CopyMark Law Group

Reg. 4893999Status 404
Filing date
Status date
Registration date
Feb 2, 2016
Examiner
CORWIN, KEVIN SCOTT
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with CERVICURA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Yoon S. Ham

Yoon S. Ham Hauptman Ham, LLP2318 Mill RoadSuite 1400Alexandria, VA 22314

Goods and services

ClassDescriptionStatusFirst use
005DNA vaccines; Pharmaceutical products and preparations, namely, for the treatment and prevention of human papilloma virus infectious disease, cancer and cervical intraepithelial neoplasia; vaccines; antibiotics; anti-cancer preparations; Drugs for medical purposes, namely, pharmaceutical drug preparations for the treatment and prevention of human papilloma virus infectious disease, cancer and cervical intraepithelial neoplasia; Injectable pharmaceuticals for medical purposes, namely, for the treatment and prevention of human papilloma virus infectious disease, cancer and cervical intraepithelial neoplasia; Cardiovascular pharmaceutical preparations for the treatment and prevention of heart and vascular diseases; Medicines for sensory organs, namely, pharmaceutical preparations for the prevention, treatment, and cure of diseases and conditions impacting the eyes, ears, nose, mouth and nervous system; Pharmaceutical preparations for digestive organs, namely, for the prevention, treatment, and cure of diseases and conditions impacting digestive organs; Dermatological pharmaceutical products; Blood solvent, namely, blood plasma, albumin, globulin, fibrinogen, thrombocyte and platelets; Pharmaceutical agents affecting metabolism; Anti-inflammatory preparations, namely, anti-inflammatory gels, ointments, salves, sprays, creams, pills, powders, granules, tablets, capsules, depots, suppository, syrup, tinctures and emulsion; Therapeutic vaccines; preventive vaccines; Pharmaceutical preparations for immunomodulatory purposes, namely, for the regulation of immune functions; Pharmaceutical preparations for the treatment of cervical cancer; Pharmaceutical preparations for the treatment of cervical intraepithelial neoplasia; pharmaceutical preparations for the treatment of cervical pre-cancer; Pharmaceutical preparations for the treatment of head and neck cancer; Pharmaceutical preparations for immunotherapy; pharmaceutical preparations for anticancer immunotherapy; Pharmaceutical preparations for gene therapy; antiviral agent against human papilloma virus; preventive vaccines against human papilloma virus infectionsSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Feb 12, 2026DENANOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED—
Feb 12, 2026DETHDEATH OF INTERNATIONAL REGISTRATION—
Nov 15, 2025DENANOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED—
Nov 15, 2025DETHDEATH OF INTERNATIONAL REGISTRATION—
Feb 7, 2025NREPNEW REPRESENTATIVE AT IB RECEIVED—
Nov 28, 2024ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Jun 18, 2023INNTTOTAL INVALIDATION PROCESSED BY THE IB—
May 24, 2023INTSTOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
May 24, 2023INPCINVALIDATION PROCESSED—
Apr 19, 2023INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Aug 19, 2022C71TCANCELLED SECTION 71—
Feb 2, 2021REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
May 28, 2020NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jul 9, 2016FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
May 3, 2016FICSFINAL DISPOSITION NOTICE SENT TO IB—
May 3, 2016FIMPFINAL DISPOSITION PROCESSED—
May 2, 2016FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Feb 2, 2016R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Nov 20, 2015GPNXNOTIFICATION PROCESSED BY IB—
Nov 17, 2015NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Nov 17, 2015PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 4, 2015OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Nov 4, 2015OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Oct 28, 2015NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Oct 15, 2015PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Oct 14, 2015CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 13, 2015TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 13, 2015CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 6, 2015ALIEASSIGNED TO LIE—
Sep 18, 2015TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 17, 2015ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 17, 2015REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Aug 28, 2015RFNTREFUSAL PROCESSED BY IB—
Aug 7, 2015RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Aug 7, 2015RFRRREFUSAL PROCESSED BY MPU—
Aug 7, 2015RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Aug 6, 2015CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 29, 2015DOCKASSIGNED TO EXAMINER—
Jun 13, 2015MAFRAPPLICATION FILING RECEIPT MAILED—
Jun 9, 2015NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jun 4, 2015REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance